The present review aimed to evaluate the apoptotic effect of tributyltin (TBT) exposure on mammalian tissues and cells in vivo. A search was conducted in specialized literature databases including Embase, Medline, Pubmed, Scholar Google, and Scopus for all manuscripts using the following keywords: \"tributyltin\", \"apoptosis\", \"mammals\", \"mammalian cells\', \"eukaryotic cells\", \'rodents\', \"rats\", \"mice\" and \"in vivo\" for all data published until September 2023. A total of 16 studies were included. The studies have demonstrated that TBT exposure induces apoptosis in cells from various mammalian organs or tissues in vivo. TBT is capable to increase apoptotic cells, to activate proapoptotic proteins such as calpain, caspases, bax and beclin-1 and to inhibit antiapoptotic protein bcl-2. Additionally, TBT alters the ratio of bcl-2/bax which favor apoptosis. Therefore, the activation of enzymes such as calpain induces apoptosis mediated by ERS and caspases through the intrinsic apoptosis pathway. This review has demonstrated that TBT exposure induces apoptosis in mammalian tissues and cells in vivo.

Plastic based products are ubiquitous due to their tremendous utility in our daily lives. However, the limited biodegradable nature of plastics has recently raised pollution concerns globally, especially micro- and nanoplastics. These anthropogenic pollutants are either manufactured specifically in the small size range for various commercial applications or formed due to fragmentation of macro plastics in the environment. Micro- and nanoplastics are currently widespread in the oceans, freshwater bodies, land and even present in our food. The biological effects of micro- and nanoplastics on aquatic organisms are well documented but their impacts on mammalian system have not been rigorously investigated. This review discusses the potential routes of exposure to micro- and nanoplastics, biological effects of these particles in mammalian cells, factors influencing toxicity, and the probable mechanisms of cytotoxicity. In general, small size, positive charge, high dose, and presence of toxic additives or pollutants in the micro/nanoplastics appear to induce cellular toxicity through oxidative stress, membrane damage, immune response and genotoxicity. Understanding the cellular fate and toxicity of these materials may help extrapolate risks to mammals.

Most of the clinical approved protein-based drugs or under clinical trials have a profound impact on the treatment of critical diseases. The mammalian eukaryotic cells culture approaches, particularly the CHO (Chinese Hamster Ovary) cells are mainly used in the biopharmaceutical industry for the mass-production of the therapeutic protein. Recent advances in CHO cell bioprocessing to yield recombinant proteins and monoclonal antibodies have enabled the expression of quality protein. The developments of cell lines are possible to enhance specific productivity. As a result, it holds an interesting area for academic as well as industrial researchers around the world. This review will focus on the recent progress of the mammalian CHO cells culture technology and the future scope of further development for the mass-production of protein therapeutics.

The generation of integral membrane proteins (IMPs) in heterologous systems and their characterization remains a major challenge in biomedical research. Significant efforts have been invested both in academia and in the pharmaceutical industry to establish technologies for the expression, isolation and characterization of IMPs. Here we summarize some of the key aspects, which are important to support structure-based drug design (SBDD) in drug discovery projects. We furthermore include timeline estimates and an overview of the target selection and biophysical screening approaches.